Pacira Pharmaceuticals (PCRX) Posts Q1 Loss of 19c/Share
Get Alerts PCRX Hot Sheet
Join SI Premium – FREE
Pacira Pharmaceuticals (NASDAQ: PCRX) reported Q1 EPS of ($0.19), $0.13 better than the analyst estimate of ($0.32). Revenue for the quarter came in at $36.7 million versus the consensus estimate of $35.4 million.
For earnings history and earnings-related data on Pacira Pharmaceuticals (PCRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- SPS Commerce (SPSC) Tops Q1 EPS by 12c
- Arca Biopharma (ABIO) Reports Q1 Loss of $0.14
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!